"Withings isn't done with CES 2026 announcements just yet. The French health tech company just announced a new partnership with Abbott. In the first quarter of the year, Abbott Lingo users will be able to view their glucose data within the Withings app. Lingo is Abbott's over-the-counter continuous glucose monitor (CGM) for nondiabetic people. Withings users will also be able to buy Lingo CGMs directly from Withings' US website, costing $89 for two sensors."
"This announcement is hardly surprising. Earlier in the show, Withings announced a new smart scale that it hopes to rebrand as a "longevity station." Metabolic health - as in glucose levels - was one of two main pillars that product focuses on. (The other being cardiovascular health.) The partnership also mirrors one between smart ring maker Oura and Dexcom, another OTC CGM maker."
Withings has partnered with Abbott to enable Abbott Lingo users to view their continuous glucose monitor (CGM) data inside the Withings app beginning in Q1. Lingo is an over-the-counter CGM aimed at nondiabetic users; Withings will sell two-sensor packs on its US website for $89. The integration supports Withings' focus on metabolic health, which complements the cardiovascular emphasis of its new smart scale positioned as a "longevity station." The partnership follows a similar consumer-facing CGM integration trend, exemplified by Oura's tie-up with Dexcom, expanding nonprescription glucose tracking across popular wearable platforms.
Read at The Verge
Unable to calculate read time
Collection
[
|
...
]